A study to confirm the reduction effect of the test food on abdominal visceral fat. -Randomized, double-blind, placebo-controlled parallel group study- - A study to confirm the reduction effect of the test food on abdominal visceral fat.

ew drug research center, Inc.0 sites44 target enrollmentJune 5, 2023

Overview

No summary available.

Registry

who.int

Start Date

June 5, 2023

End Date

November 25, 2023

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

ew drug research center, Inc.

•1\) Subjects who are under treatment or have a history of severe illness in the heart, liver, kidney, digestive organs or other organs 2\) Subjects who are under treatment of dyslipidemia, high blood pressure, or diabetes 3\) Subjects who received medication treatment or surgery due to serious illness or injury within 1 month from the start of this study 4\) Subjects who regularly use health foods and supplements affecting the study 5\) Possible pregnancy, pregnancy, and lactation 6\) Heavy drinkers 7\) Subjects who have experienced feel bad mood by blood collection 8\) Subjects who donated 200 mL or more of blood within 1 month from the start of the study or subjects who plan to do so during the study period 9\) Subjects who defecate less than once a week 10\) Night Rotation worker 11\) Subjects who plan business trip or trip for 10 days or more a month 12\) Subjects who have allergy related to the test foods 13\) Subjects with claustrophobia that interferes with CT scans, subjects with metal in the CT scan measurement site due to surgery, subjects with implanted medical devices such as cardiac pacemakers, implantable cardioverter defibrillators 14\) Subjects already participating in other clinical trials 15\) Subjects who are ineligible due to physician's judgment